Point72 Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-658,695
Closed -$37M 2971
2023
Q3
$37M Buy
658,695
+600,821
+1,038% +$33.8M 0.11% 240
2023
Q2
$2.92M Sell
57,874
-1,012,626
-95% -$53.9M 0.01% 964
2023
Q1
$58.4M Buy
+1,070,500
New +$62.5M 0.18% 143
2022
Q3
Sell
-497,446
Closed -$28.2M 1798
2022
Q2
$28.2M Buy
497,446
+278,060
+127% +$15.2M 0.12% 233
2022
Q1
$13.7M Buy
+219,386
New +$11.8M 0.05% 424
2021
Q2
Sell
-165,787
Closed -$9.93M 1212
2021
Q1
$9.93M Buy
+165,787
New +$9.01M 0.05% 427
2020
Q4
Sell
-530,819
Closed -$27.1M 1187
2020
Q3
$27.1M Buy
530,819
+31,248
+6% +$1.3M 0.14% 206
2020
Q2
$17.5M Sell
499,571
-364,150
-42% -$12.5M 0.11% 234
2020
Q1
$21.9M Buy
863,721
+574,502
+199% +$17.1M 0.18% 164
2019
Q4
$8.01M Buy
+289,219
New +$6.9M 0.04% 413
2019
Q1
Sell
-282,608
Closed -$4.27M 1279
2018
Q4
$4.27M Buy
+282,608
New +$4.21M 0.02% 590

Other funds holding AXNX

Point72 Asset Management's AXNX Position: Q4 2023 in Review

Point72 Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2023, closing a stake of 658,695 shares — an estimated $37M sold.

Point72 Asset Management first reported a position in AXNX in Q4 2018 and held it in 11 quarters. The position peaked at $58.4M in Q1 2023. 229 funds tracked by Wall St. Rank hold AXNX as of Q4 2023.

  • Point72 Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Point72 Asset Management sold 658,695 Axonics, Inc. Common Stock shares in Q4 2023, an estimated $37M.
  • Point72 Asset Management first reported a position in Axonics, Inc. Common Stock in Q4 2018 and held it in 11 quarters.
  • Point72 Asset Management's Axonics, Inc. Common Stock position peaked at $58.4M in Q1 2023.
  • 229 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2023.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.